Sanofi announces sales transfer of anticancer agent JEVTANA to Taiho in Japan

Sanofi K.K. and Taiho Pharmaceutical have announced that the sales of the anticancer agent Jevtana® I.V. Infusion 60...

January 6, 2026 | Tuesday | News
Singapore's Hyphens Pharma out-licences Cerapro® MED to six European countries

Singapore-based Hyphens Pharma International has granted the rights to commercialise its innovative product, Cerapro®...

January 5, 2026 | Monday | News
Insilico Medicine announces $888 M multi-year collaboration with Servier for drug discovery in oncology

Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...

January 5, 2026 | Monday | News
Taiwan's ScinoPharm secures US FDA approval of Glatiramer Acetate Injection for MS treatment

ScinoPharm Taiwan has announced a landmark achievement in the global pharmaceutical landscape, securing US Food and Drug...

January 5, 2026 | Monday | News
Shionogi expands rare disease presence with acquisition of global rights to Tanabe’s RADICAVA for $2.5 B

Japan's Shionogi & Co. will acquire a newly established company that Tanabe Pharma Corporation will create to hold t...

January 2, 2026 | Friday | News
Insilico Medicine lists on Hong Kong Stock Exchange, showing largest Hong Kong biotech IPO

Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...

January 2, 2026 | Friday | News
Mabwell's Adalimumab Biosimilar receives marketing approval in Indonesia

China-based Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, has announce...

January 2, 2026 | Friday | News
Korean startup KLMBio accelerates global expansion in bone graft market

South Korea-based KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global ...

January 2, 2026 | Friday | News
“There are talent shortages in specialised modalities such as ADCs, peptides, and computational biology”

How would KBI Biopharma highlight its achievements in 2025? Which key projects strengthened the company’s global C...

January 3, 2026 | Saturday | Opinion
Momentum in Motion: What Will Shape APAC’s Life Sciences Landscape in 2026?

Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...

January 3, 2026 | Saturday | Opinion
Lupin signs agreement with Gan & Lee Pharma for novel GLP-1 receptor agonist

Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...

December 29, 2025 | Monday | News
Fujifilm announces opening of one of Japan’s largest Bio CDMO facilities

Fujifilm Corporation has announced the completion of one of Japan’s largest bio CDMO facilities (the new plan...

December 26, 2025 | Friday | News
Sanofi buys Dynavax for $2.2 B to augment presence in adult immunisation sector

French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation,...

December 26, 2025 | Friday | News
Singapore-based startup Aevice Health announces expansion into Australian market

AeviceMD Monitoring System, a non-invasive wearable respiratory monitoring solution developed by Singapore-based Aevice ...

December 23, 2025 | Tuesday | News
Asahi Kasei Pharma to relocate global R&D hub to Shonan iPark in Japan

Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture ...

December 23, 2025 | Tuesday | News
Japan's Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery

Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...

December 19, 2025 | Friday | News
US-based Hyperfine receives regulatory approval of Swoop® System in India for brain imaging

US-based Hyperfine, Inc., the groundbreaking health technology company that has redefined brain imaging with the fi...

December 18, 2025 | Thursday | News
Japan's PRISM BioLab partners with US-based startup Talus Bioscience for AI-based drug discovery

Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel...

December 18, 2025 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls